Too many targets, but how many are viable?

Functional genomics is helping the pharmaceutical industry in generating large numbers of potential gene targets from several sources such as gene expression, genotyping and through biomarker discovery. Pharmacogenomics applies these genomic technologies to drugs in clinical development increasing the efficiency and speed of drug development. Genomics application in drug discovery has paved the way for targeted therapies and personalized medicine programs in several pharmaceutical companies.

• Comparative gene expression analysis of blood and brain
• Screening biomarkers and toxicology panels for analyzing pathways, target classes and disease sets
• Cancer metastasis and prognosis of tumors using miRNA profiling
• Hypothesis driven gene and disease association studies, SNPs
• Tissue expression patterns of candidate genes using microarrays
• Evaluate functional mechanisms and potential toxicity of drug candidates using q-RT-PCR and microarrays
• Enhance productivity through translational biomarkers

In today’s challenging financial environment, the merits of outsourcing the pharmacogenomics work to a service provider far outweighs the cost involved in building this capability. With over 2/3rd of the top pharma and biotechs as our clients and having established the world’s largest commercial microarray facility over several years, Gene Logic becomes your trusted partner in your discovery pursuits.